Related Experiment Video
Updated: Aug 2, 2026

Lavage-induced Surfactant Depletion in Pigs As a Model of the Acute Respiratory Distress Syndrome (ARDS)
Published on: September 7, 2016
Perfluorocarbon priming and surfactant: physiologic and pathologic effects
J D Mrozek1, K M Smith, S C Simonton
1Infant Pulmonary Research Center, Children's Health Care of St. Paul, MN 55102, USA.
Perfluorocarbon (PFC) priming did not enhance surfactant therapy in a piglet model of lung injury. Surfactant alone improved lung function and reduced injury, without added benefit from PFC priming.
Area of Science:
- Neonatal physiology
- Respiratory medicine
- Pulmonary research
Background:
- Lung injury in newborns often requires respiratory support.
- Surfactant therapy is a cornerstone in managing neonatal respiratory distress.
- Perfluorocarbons (PFCs) have been explored as potential adjuncts to surfactant therapy.
Purpose of the Study:
- To evaluate if perfluorocarbon (PFC) priming improves gas exchange and lung compliance.
- To determine if PFC priming reduces lung injury compared to surfactant alone.
- To test the hypothesis that PFC priming enhances the efficacy of exogenous surfactant.
Main Methods:
- A prospective, randomized animal study was conducted on 32 newborn piglets.
- Animals underwent induced lung injury via saline washout.
- Four groups received: surfactant alone, PFC (perflubron) alone, PFC followed by surfactant, or no treatment (control).
Main Results:
- All treated groups showed improved oxygenation indices and respiratory system compliance compared to controls.
- PFC-primed and surfactant-only groups required lower mean airway pressures and had higher pH levels than controls.
- Histopathologic analysis revealed less lung injury in the surfactant-only group compared to PFC-treated or control groups.
Conclusions:
- Perfluorocarbon priming did not offer significant physiologic benefits over surfactant therapy alone.
- PFC priming did not improve lung pathology in this animal model of lung injury.
- Exogenous surfactant alone demonstrated efficacy in improving lung function and reducing injury.
More Related Videos
09:36Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
Published on: September 24, 2020
08:58Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs
Published on: October 31, 2025
Related Concept Videos
Breathing
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Pulmonary Cycle: Exhalation
Micelles
Chronic Obstructive Pulmonary Disease II: Emphysema
Pulmonary Edema II: Pathophysiology